Therapeutic Advances in Drug Safety is a prestigious open-access journal published by SAGE Publications Ltd that has made significant strides in the field of pharmacology since its inception in 2010. With an impressive impact factor that places it in the Q1 category for Pharmacology (medical), this journal ranks 61st out of 272 in Scopus, showcasing its global influence and commitment to advancing drug safety research. Based in the United Kingdom, it aims to bridge the critical gap between pharmacological innovation and clinical application, offering a platform for the dissemination of groundbreaking research, case studies, and expert reviews. Since adopting an Open Access model in 2019, the journal has significantly increased its reach, ensuring that vital findings in drug safety are accessible to researchers, healthcare professionals, and educators worldwide. As the field of drug safety continues to evolve, Therapeutic Advances in Drug Safety remains an essential resource for those dedicated to enhancing safe therapeutic practices and patient outcomes.

Therapeutics and Clinical Risk Management is a pioneering journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the fields of medication safety, pharmacology, and clinical risk management through rigorous research and comprehensive reviews. With an impact factor that demonstrates its significance within various disciplines, this Open Access journal has been instrumental since its inception in 2006, promoting the dissemination of knowledge to a global audience without barriers. With its reach spanning categories such as Pharmacology, Medicine, and Chemical Health and Safety, it champions innovative practices and risk assessment methodologies. The journal is recognized in the Q2 quartile for multiple related categories and excels in rank within its field, highlighting its influential contributions to safety and therapeutic practices. By prioritizing the sharing of impactful research, Therapeutics and Clinical Risk Management serves as an indispensable resource for researchers, professionals, and students aiming to enhance clinical outcomes and mitigate risks in therapeutic paradigms.

The Journal of Patient Safety, published by Lippincott Williams & Wilkins, is a premier scholarly journal dedicated to advancing the field of patient safety through empirical research, innovative practices, and critical insights. Established in 2006, this journal has rapidly gained recognition, currently holding a prestigious Q1 ranking in Leadership and Management and a Q2 ranking in Public Health, Environmental and Occupational Health for 2023, reflecting its significant impact within these disciplines. With an impressive rank of #7 in Nursing Leadership and Management and #211 in Medicine Public Health as recorded in Scopus, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to improving patient safety and outcomes. The journal does not operate as an open access publication; however, its comprehensive scope and high-quality articles underscore its dedication to disseminating crucial knowledge in a field that is ever-evolving. Joining the readership of the Journal of Patient Safety means becoming part of a vital conversation aimed at redefining standards of care and enhancing safety protocols across various healthcare settings.

American Journal of Medical Quality is a pivotal publication in the field of healthcare quality and medical policy, published by Lippincott Williams & Wilkins. Since its inception in 1992, the journal has become a critical resource for researchers, practitioners, and students dedicated to improving patient care and health systems through evidence-based practices. With a current impact factor that reflects its significance in the arena of medicine and health policy, the journal falls within the Q3 category in both Health Policy and Medicine (Miscellaneous) as of 2023, ranking 253rd out of 636 in general medicine according to Scopus metrics. This underscores its relevance and prominence among peers. The journal's scope encompasses a diverse range of topics related to quality improvement initiatives, healthcare delivery systems, and policy analysis, making it an essential read for anyone invested in advancing medical quality standards and practices. While it is not an open-access journal, the content is meticulously curated to enrich the academic discourse and inform best practices in medical quality. With an ongoing commitment to addressing contemporary challenges in healthcare, American Journal of Medical Quality serves as an influential platform for advancing the knowledge and implementation of quality initiatives in medical settings.

ANESTHESIOLOGY, the premier journal in the field of anesthesiology and pain medicine, is published by Lippincott Williams & Wilkins and holds a prestigious Q1 category ranking as of 2023. With a rich history dating back to 1945, this journal serves as a vital resource for the dissemination of cutting-edge research, expert reviews, and clinical practice guidelines aimed at improving patient care and safety in anesthesia. With a remarkable impact factor and an esteemed ranking of 5 out of 136 in the category of medicine, it showcases work from leading researchers in the field, contributing to a 96th percentile Scopus rank. Although it does not offer open access, ANESTHESIOLOGY provides numerous subscription options that ensure comprehensive access to pivotal findings and advancements that shape modern anesthetic practice. This journal is indispensable for anesthesiologists, clinicians, and researchers dedicated to the innovation and refinement of anesthetic techniques, pain management, and perioperative care.

The Turkish Journal of Anaesthesiology and Reanimation is an esteemed academic publication dedicated to advancing the fields of anesthesiology and pain medicine, as well as emergency medicine. Published by GALENOS PUBL HOUSE, this open access journal has been serving the global academic community since 2019, allowing for unrestricted dissemination of research findings and clinical practices. With its current categorization in the Q3 quartile for both anesthesiology and emergency medicine, the journal provides a valuable platform for researchers, professionals, and students alike, featuring rigorous peer-reviewed articles that enhance knowledge and inspire innovation. Located in Istanbul, Turkey, the journal actively contributes to an important dialogue in healthcare, making it a significant resource for those involved in improving patient care and outcomes. Researchers can also benefit from its increasing visibility, reflected in its Scopus rankings, positioning it within the competitive landscape of medical literature. Engage with cutting-edge research and ensure your contributions stand out in this vital field.

Journal of Pharmaceutical Health Services Research, published by Oxford University Press, stands as a vital resource within the fields of pharmacology, toxicology, and health economics. With a focus on the integration of pharmaceutical science and healthcare services, this journal addresses the rapidly evolving challenges faced by researchers and practitioners alike, promoting innovative solutions that can enhance patient care and improve health outcomes. Its Q3 ranking in key categories such as Economics and Pharmacology further highlights its significance in the academic landscape. Although not an open-access journal, the Journal of Pharmaceutical Health Services Research provides a platform for high-quality research and comprehensive reviews, making it an essential reference for those dedicated to advancing knowledge and practice in pharmaceutical health services. With converged years from 2010 to 2024, the journal continues to contribute valuable insights that foster collaboration among academics, industry professionals, and policymakers, reinforcing its role as a cornerstone of pharmaceutical research and health service innovation.

Drug Healthcare and Patient Safety is a premier Open Access journal, published by DOVE MEDICAL PRESS LTD since 2009, dedicated to advancing the understanding and practices surrounding medication safety and healthcare delivery. With its ISSN 1179-1365 and E-ISSN matching, this New Zealand-based journal not only fosters global discourse but also prioritizes the dissemination of research that intersects both health policy and pharmacology. Categorized as Q2 in Health Policy and Q3 in Pharmacology for the year 2023, it occupies a notable position within the academic community, as reflected by its Scopus rankings, which place it in the 66th and 45th percentiles of its respective categories. Drug Healthcare and Patient Safety aims to provide a platform for researchers, practitioners, and students to share innovative findings, promote safe medication practices, and explore the implications of health policy on patient outcomes. As an Open Access journal, it ensures that vital research is accessible to a wider audience, making significant contributions to the ongoing dialogue in the fields of healthcare and pharmacovigilance.

Pediatric Quality & Safety is an esteemed Open Access journal aimed at enhancing the well-being and care of pediatric patients through rigorous research and innovative practices. Published by Lippincott Williams & Wilkins since 2016, this journal provides a platform for the dissemination of critical findings in the fields of pediatrics, perinatology, and child health, boasting a respectable impact factor that places it in the Q2 category for 2023, ranking #173 out of 330 in its field. With a commitment to improving healthcare outcomes, Pediatric Quality & Safety not only offers comprehensive coverage of current research trends but also promotes best practices among healthcare professionals. It welcomes contributions from researchers, clinicians, and students alike, making it an invaluable resource for anyone dedicated to advancing pediatric care. The journal is accessible for readers worldwide, reflecting a growing emphasis on open-access knowledge and collaboration.

BMJ Open Quality, published by the esteemed BMJ Publishing Group, is an influential open access journal that has been a vital platform for advancing the quality of healthcare since its inception in 2017. Based in the United Kingdom, this journal focuses on a diverse range of topics within health policy, leadership and management, and public health, catering specifically to professionals, researchers, and students eager to explore the intersection of quality improvement and healthcare delivery. With an impressive ranking in Scopus categories, including Q2 in Health Policy and Leadership and Management, BMJ Open Quality fosters a multidisciplinary dialogue that addresses the pressing challenges facing the healthcare sector today. Researchers will find robust access options, allowing for unrestricted sharing of valuable findings, thereby enhancing collaboration and innovation in the field. Positioned at the forefront of quality enhancement methodologies, BMJ Open Quality is indispensable for those dedicated to driving systematic changes in health services.